BDX Becton Dickinson & Company

  1. Stocks
  2. Healthcare
  3. NYSE: BDX

Price (delayed)

$188.89

Market cap

$51.45B

P/E Ratio

56.89

Dividend/share

$4.2

EPS

$3.32

Enterprise value

$67.4B

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 74
Relative Valuation: Rel. Valuation: 32
Relative Profitability: Rel. Profitability: 45

Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used ...

Highlights
The debt has contracted by 13% YoY and by 2.7% from the previous quarter
Becton Dickinson's gross profit has increased by 10% YoY
The price to earnings (P/E) is 51% more than the last 4 quarters average of 37.3 and 31% more than the 5-year quarterly average of 43.2
Becton Dickinson's net income has decreased by 41% YoY and by 17% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.bd.com
Peers: TMO XRAY ISRG BAX

Key stats

What are the main financial stats of BDX

BDX stock price

How has the Becton Dickinson stock price performed over time
Intraday
0.81%
1 week
4.85%
1 month
3.27%
1 year
0.28%
YTD
-2.67%
QTD
5.53%

Financial performance

How have Becton Dickinson's revenue and profit performed over time
Revenue
$20.84B
Gross profit
$9.68B
Operating income
$2B
Net income
$941M
Gross margin
46.4%
Net margin
4.5%
The net margin has contracted by 44% YoY and by 18% from the previous quarter
Becton Dickinson's net income has decreased by 41% YoY and by 17% from the previous quarter
Becton Dickinson's operating margin has decreased by 14% YoY and by 5% QoQ
Becton Dickinson's gross profit has increased by 10% YoY

Price vs fundamentals

How does BDX's price correlate with its fundamentals

Growth

What is Becton Dickinson's growth rate over time

Valuation

What is Becton Dickinson stock price valuation
BDX P/E details
P/E
56.89
P/B
2.13
P/S
2.5
EV/EBIT
38.82
EV/EBITDA
16.59
EV/Sales
3.23
The price to earnings (P/E) is 51% more than the last 4 quarters average of 37.3 and 31% more than the 5-year quarterly average of 43.2
Becton Dickinson's EPS has decreased by 40% YoY and by 16% QoQ
The price to book (P/B) is 19% less than the 5-year quarterly average of 2.6 but 6% more than the last 4 quarters average of 2.0
Becton Dickinson's equity has decreased by 4.1% YoY
The P/S is 25% lower than the 5-year quarterly average of 3.3 but 8% higher than the last 4 quarters average of 2.3
Becton Dickinson's revenue has increased by 5% YoY

Efficiency

How efficient is Becton Dickinson business performance
Becton Dickinson's return on equity has decreased by 39% YoY and by 16% QoQ
The return on assets has declined by 38% year-on-year and by 14% since the previous quarter
Becton Dickinson's return on sales has decreased by 34% YoY and by 14% QoQ
The return on invested capital has declined by 24% year-on-year and by 7% since the previous quarter

Dividends

What is BDX's dividend history
Dividend details
DPS
$4.2
Dividend yield
2.22%
Payout ratio
126.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Becton Dickinson financials performed over time
Becton Dickinson's total assets is 93% more than its total liabilities
Becton Dickinson's quick ratio has decreased by 26% YoY and by 11% QoQ
The current ratio has contracted by 21% YoY and by 7% from the previous quarter
The debt is 31% less than the equity
The debt has contracted by 13% YoY and by 2.7% from the previous quarter
The debt to equity fell by 9% YoY and by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.